日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease

一项使用福斯他替尼抑制SYK活性预防和治疗慢性移植物抗宿主病的I期临床试验

Lin, Chenyu; DiCioccio, Rachel A; Haykal, Tarek; McManigle, William C; Li, Zhiguo; Anand, Sarah M; Poe, Jonathan C; Bracken, Sonali J; Jia, Wei; Alyea, Edwin P 3rd; Cardones, Adela R; Choi, Taewoong; Gasparetto, Cristina; Grunwald, Michael R; Hennig, Therese; Kang, Yubin; Long, Gwynn D; Lopez, Richard; Martin, Melissa; Minor, Kerry K; Quinones, Victor L Perez; Sung, Anthony D; Wiggins, Kristi; Chao, Nelson J; Horwitz, Mitchell E; Rizzieri, David A; Sarantopoulos, Stefanie

Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation

急性髓系白血病(AML)患者在接受匹配无关亲缘异基因造血干细胞移植后复发,并伴有复发性遗传性HLA丢失。

Jan, Max; Leventhal, Matthew J; Morgan, Elizabeth A; Wengrod, Jordan C; Nag, Anwesha; Drinan, Samantha D; Wollison, Bruce M; Ducar, Matthew D; Thorner, Aaron R; Leppanen, Scott; Baronas, Jane; Stevens, Jonathan; Lane, William J; Kekre, Natasha; Ho, Vincent T; Koreth, John; Cutler, Corey S; Nikiforow, Sarah; Alyea, Edwin P 3rd; Antin, Joseph H; Soiffer, Robert J; Ritz, Jerome; Lindsley, R Coleman; Ebert, Benjamin L

High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML

诊断时NPM1突变等位基因负荷高预示着新发急性髓系白血病预后不良。

Patel, Sanjay S; Kuo, Frank C; Gibson, Christopher J; Steensma, David P; Soiffer, Robert J; Alyea, Edwin P 3rd; Chen, Yi-Bin A; Fathi, Amir T; Graubert, Timothy A; Brunner, Andrew M; Wadleigh, Martha; Stone, Richard M; DeAngelo, Daniel J; Nardi, Valentina; Hasserjian, Robert P; Weinberg, Olga K

α(1)-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease

α(1)-抗胰蛋白酶输注治疗类固醇耐药性急性移植物抗宿主病

Magenau, John M; Goldstein, Steven C; Peltier, Dan; Soiffer, Robert J; Braun, Thomas; Pawarode, Attaphol; Riwes, Mary M; Kennel, Maggi; Antin, Joseph H; Cutler, Corey S; Ho, Vincent T; Alyea, Edwin P 3rd; Parkin, Brian L; Yanik, Gregory A; Choi, Sung Won; Lewis, Eli C; Dinarello, Charles A; Koreth, John; Reddy, Pavan

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results

硼替佐米为基础的免疫抑制方案在减低强度预处理造血干细胞移植后的疗效:随机II期临床试验结果

Koreth, John; Kim, Haesook T; Lange, Paulina B; Poryanda, Samuel J; Reynolds, Carol G; Rai, Sharmila Chamling; Armand, Philippe; Cutler, Corey S; Ho, Vincent T; Glotzbecker, Brett; Yusuf, Rushdia; Nikiforow, Sarah; Chen, Yi-Bin; Dey, Bimalangshu; McMasters, Malgorzata; Ritz, Jerome; Blazar, Bruce R; Soiffer, Robert J; Antin, Joseph H; Alyea, Edwin P 3rd

A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation

一项针对异基因造血干细胞移植后复发患者的CD25/调节性T细胞耗竭供体淋巴细胞输注的I期研究

Nikiforow, Sarah; Kim, Haesook T; Daley, Heather; Reynolds, Carol; Jones, Kyle Thomas; Armand, Philippe; Ho, Vincent T; Alyea, Edwin P 3rd; Cutler, Corey S; Ritz, Jerome; Antin, Joseph H; Soiffer, Robert J; Koreth, John

Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation

在减低强度动员外周血异基因造血干细胞移植中,输注的总有核细胞剂量比CD34+细胞数量更能预测移植结果。

Martin, Paul S; Li, Shuli; Nikiforow, Sarah; Alyea, Edwin P 3rd; Antin, Joseph H; Armand, Philippe; Cutler, Corey S; Ho, Vincent T; Kekre, Natasha; Koreth, John; Luckey, C John; Ritz, Jerome; Soiffer, Robert J

A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial

基于硼替佐米的治疗方案在清髓性HLA不匹配和无关供者移植中显示出良好的生存率和移植物抗宿主病预防效果:一项II期试验

Koreth, John; Kim, Haesook T; Lange, Paulina B; Bindra, Bhavjot; Reynolds, Carol G; Chammas, Marie J; Armand, Philippe; Cutler, Corey S; Ho, Vincent T; Glotzbecker, Brett; Nikiforow, Sarah; Ritz, Jerome; Blazar, Bruce R; Soiffer, Robert J; Antin, Joseph H; Alyea, Edwin P 3rd

White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcome

异基因造血干细胞移植后白细胞恢复情况可预测临床结果

Kim, Haesook T; Frederick, David; Armand, Philippe; Andler, Emily; Kao, Grace; Cutler, Corey; Koreth, John; Alyea, Edwin P 3rd; Antin, Joseph H; Soiffer, Robert J; Ritz, Jerome; Ho, Vincent T

Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation

在HLA不匹配的非亲缘供者移植中,基于硼替佐米的移植物抗宿主病预防

Koreth, John; Stevenson, Kristen E; Kim, Haesook T; McDonough, Sean M; Bindra, Bhavjot; Armand, Philippe; Ho, Vincent T; Cutler, Corey; Blazar, Bruce R; Antin, Joseph H; Soiffer, Robert J; Ritz, Jerome; Alyea, Edwin P 3rd